SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 Long-Term Survival of the GeparOLA Study: Neoadjuvant Paclitaxel/Olaparib vs. Paclitaxel/Carboplatinum in Patients With HER2- BC and Homologous Recombination Deficiency
By
SABCS 2022 Conference Coverage
FEATURING
Peter Fasching
By
SABCS 2022 Conference Coverage
FEATURING
Peter Fasching
89 views
January 20, 2023
Login to view comments.
Click here to Login
Videos